인쇄하기
취소
|
Ministry of Health and Welfare is pushing the amendment of "List of drug for insurance benefits and their upper bound price".
Bayer Korea has recently negotiated with National Health Insurance Service that both pre-filled syringe and injection as 996,243 won. Novartis Korea registered 'Lucentis(ranibizumab)' as 1,042,767 won per 0.3ml bottle. The price of Otsuka Korea's 'Ablify OD tablet' 10mg...